Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Matoba

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Heart (British Cardiac Society)|July 15, 2021
Aspirin versus P2Y<sub>12</sub> inhibitors with anticoagulation therapy for atrial fibrillationHidehira Fukaya, Junya Ako, Satoshi Yasuda, et al.
Nature Medicine|May 12, 2009
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysmsKimio Satoh, Patrizia Nigro, Tetsuya Matoba, et al.
Journal of Arrhythmia|November 21, 2025
Association Between History of Rhythm Control Therapy and Clinical Outcomes in Atrial Fibrillation Patients With Stable Coronary Artery Disease: A Sub-Analysis of the AFIRE TrialDaisuke Wakatsuki, Hiroshi Suzuki, Koichi Kaikita, et al.
Thrombosis and Haemostasis|June 13, 2022
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial FindingsHiroyuki Arashi, Junichi Yamaguchi, Nobuhisa Hagiwara, et al.
JACC. Asia|January 30, 2023
Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index CategoriesMasanobu Ishii, Koichi Kaikita, Satoshi Yasuda, et al.
Journal of the American Heart Association|October 10, 2023
Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE StudyRaisuke Iijima, Masahide Tokue, Masato Nakamura, et al.
JACC. Asia|March 4, 2026
Medication Adherence and Antithrombotic Therapy Outcomes: Insights From a Post Hoc Analysis of the AFIRE TrialNaoki Chiba, Takashi Noda, Kotaro Nochioka, et al.
International Heart Journal|February 26, 2019
Architecture of the Japan Ischemic Heart Disease Multimodal Prospective Data Acquisition for Precision Treatment (J-IMPACT) SystemTetsuya Matoba, Takahide Kohro, Hideo Fujita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 5, 2019
Prognostic Value of Neurological Status on Hospital Arrival for Short-Term Outcome in Patients With Cardiovascular Shock - Sub-analysis of the Japanese Circulation Society Cardiovascular Shock RegistryYasushi Ueki, Masahiro Mohri, Tetsuya Matoba, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteriesKaku Nakano, Kensuke Egashira, Seigo Masuda, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Heart (British Cardiac Society)|July 15, 2021
Aspirin versus P2Y<sub>12</sub> inhibitors with anticoagulation therapy for atrial fibrillationHidehira Fukaya, Junya Ako, Satoshi Yasuda, et al.
Nature Medicine|May 12, 2009
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysmsKimio Satoh, Patrizia Nigro, Tetsuya Matoba, et al.
Journal of Arrhythmia|November 21, 2025
Association Between History of Rhythm Control Therapy and Clinical Outcomes in Atrial Fibrillation Patients With Stable Coronary Artery Disease: A Sub-Analysis of the AFIRE TrialDaisuke Wakatsuki, Hiroshi Suzuki, Koichi Kaikita, et al.
Thrombosis and Haemostasis|June 13, 2022
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial FindingsHiroyuki Arashi, Junichi Yamaguchi, Nobuhisa Hagiwara, et al.
JACC. Asia|January 30, 2023
Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index CategoriesMasanobu Ishii, Koichi Kaikita, Satoshi Yasuda, et al.
Journal of the American Heart Association|October 10, 2023
Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE StudyRaisuke Iijima, Masahide Tokue, Masato Nakamura, et al.
JACC. Asia|March 4, 2026
Medication Adherence and Antithrombotic Therapy Outcomes: Insights From a Post Hoc Analysis of the AFIRE TrialNaoki Chiba, Takashi Noda, Kotaro Nochioka, et al.
International Heart Journal|February 26, 2019
Architecture of the Japan Ischemic Heart Disease Multimodal Prospective Data Acquisition for Precision Treatment (J-IMPACT) SystemTetsuya Matoba, Takahide Kohro, Hideo Fujita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 5, 2019
Prognostic Value of Neurological Status on Hospital Arrival for Short-Term Outcome in Patients With Cardiovascular Shock - Sub-analysis of the Japanese Circulation Society Cardiovascular Shock RegistryYasushi Ueki, Masahiro Mohri, Tetsuya Matoba, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteriesKaku Nakano, Kensuke Egashira, Seigo Masuda, et al.
Pageof 17